New Delhi, July 28, 2022: Scientists have found that Covaxin, which is an inactivated whole-virion vaccine, induces robust immune memory to SARS-CoV-2 and variants of concern that persist for at least 6 months after vaccination and induces memory T cells that can respond robustly against the variants. Covaxin may help in controlling the virus load […]
Tag: COVAXIN
DCGI approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 Years
New Delhi, May 13, 2021: The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III clinical trial of Covaxin (COVID vaccine) in the age group 2 to 18 years, to its manufacturer Bharat […]
Modi Govt: Reports alleging that Centre has not placed any fresh order for COVID 19 Vaccines are Incorrect
New Delhi, May 4, 2021: Modi government yesterday bashed reports stating that the central government has not placed any fresh order for COVID 19 Vaccines. In a lengthy statement Ministry of Health and Family Welfare stated: There have been some media reports alleging that the Centre has not placed any fresh order for COVID 19 […]
Phase 3 Clinical Trial of COVAXIN, developed by ICMR & Bharat Biotech, shows 81% efficacy
New Delhi, March 4, 2021: Phase 3 results of the COVAXIN, developed by Indian Council of Medical Research (ICMR)in partnership with Bharat BiotechInternational Limited (BBIL),has shown an interim vaccine efficacy of 81% in preventing Covid-19. The Phase 3 trial,jointly initiated by ICMR and BBIL in mid-November 2020,was conducted in a total of 25,800 individualsacross 21 […]